Form 8-K - Current report:
SEC Accession No. 0001493152-21-016564
Filing Date
2021-07-09
Accepted
2021-07-09 17:30:11
Documents
1
Period of Report
2021-07-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 47493
  Complete submission text file 0001493152-21-016564.txt   48669
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39717 | Film No.: 211083663
SIC: 2834 Pharmaceutical Preparations